2-(Acetylamino)-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactose

Catalog No. :
ACUTIJ726
CAS No. :
3554-90-3
Molecular Formula :
C14H25NO11
Molecular Weight :
383.35

IUPAC Name:N-((2R,3R,4S,5R)-4,5,6-trihydroxy-1-oxo-3-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide

2-(Acetylamino)-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactose structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Acetylamino)-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactose
IUPAC NameN-((2R,3R,4S,5R)-4,5,6-trihydroxy-1-oxo-3-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide
Molecular FormulaC14H25NO11
Molecular Weight383.35
SMILESCC(N[C@H]([C@@H](O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)[C@@H](O)[C@H](O)CO)C=O)=O
InChI KeyQCQYVCMYGCHVMR-AAZUGDAUSA-N
SynonymT ANTIGEN;THOMSEN-FRIEDENREICH ANTIGEN;TF ANTIGEN;3]-D-GALNAC;beta-galactosyl(1-3)-N-acetylgalactosamine;2-ACETAMIDO-2-DEOXY-3-O-(BETA-D-GALACTOPYRANOSYL)-D-GALACTOPYRANOSE;2-ACETAMIDO-2-DEOXY-3-O-(BETA-D-GALACTOPYRANOSYL)-D-GALACTOSE;GAL-BETA1,3GALNAC
CAS No.3554-90-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUTIJ726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUTIJ726 route product structure diagram
    ACUTIJ7263554-90-3
Inquiry

2. ACUTIJ726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUTIJ726 route product structure diagram
    ACUTIJ7263554-90-3
Inquiry

Comments (0)